INTERNATIONAL PATENT: LEPU BIOPHARMA CO., LTD. FILES APPLICATION FOR "ANTI-DLL3 ANTIBODIES AND USES THEREOF"

GENEVA, Sept. 21 -- LEPU BIOPHARMA CO., LTD. (Floor 2, Building 4, No. 651 Lianheng Road, PujiangMinhang District, Shanghai 201112) filed a patent application (PCT/CN2025/081887) for "ANTI-DLL3 ANTIBODIES AND USES THEREOF" on Mar 11, 2025. With publication no. WO/2025/190281, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAI, Zhijian (Floor 3, Building 4, No. 651 Lianheng Road, PujiangMinhang District, Shanghai 201112), WU, Xin (Floor 3, Building 4, No. 651 Lianheng Road, PujiangMinhang District, Shanghai 201112), CUI, ...